Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Drug Discovery (3)
182 Articles Available
3
8
Can't find what you're looking for? Try our
advanced search
.
Chronokines
Delivering Breakthrough Medicines for Rare Hematologic Diseases and Cancers
PAP-Q2-20-CL-003
Molecules
Molecules that Changed Medicine
PAP-Q2-20-NI-002
Chronokines
Solving Unmet Clinical Needs by Harnessing the Science of Aging
PAP-Q2-20-CL-013
Cancer Therapies
Computational Discoveries for Clinical Development of Novel Cancer Therapies
PAP-Q2-20-CL-014
Drug Repositioning
A Therapeutic Strategy for Neurological Disorders
PAP-Q2-20-CL-016
Immunotherapy
Leveraging the Native Immune Response to Fight Cancer
PAP-Q2-20-CL-017
Novel Antibiotics
Applying a Synthetic Approach to the Development of a New Generation of Antibiotics
PAP-Q2-20-CL-019
Epigenetics
Epigenetic Regulation to Treat Acute Organ Injury and Chronic Liver Diseases
PAP-Q2-20-CL-022
Endocrine Diseases
Developing Transformative Treatments for Rare Endocrine Diseases
PAP-Q2-20-CL-023
Cancer and Neurodegenerative Diseases
Leveraging the Cell Cytoskeleton for the Treatment of Cancer and Neurodegenerative Diseases
PAP-Q2-20-CL-024
Roundtable
Q: What two or three drug molecules do you identify as having had the greatest impact on society? What about on the pharmaceutical industry?
PAP-Q2-20-RT-002
H1N1
Seaweed Extract Reduces Flu Severity
PR-M05-20-NI-018
Bioinformatics
Leveraging Bioinformatics for Nontraditional Drug Discovery
PAP-Q1-20-CL-013
Google Cloud
Schrödinger Taps Google Cloud’s High-Performance Compute (HPC) Solution to Bolster Its Drug Discovery Efforts
PR-M03-20-NI-001
Collaboration
NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration For Ulcerative Colitis
PR-M01-20-NI-030
Drug Discovery Platform
Cellarity Founded to Identify New Drugs that Target Specific Cellular Behaviors
PAO-M12-19-NI-004
Artificial Intelligence
Artificial Intelligence Expected to Improve Pharma R&D
PAO-M12-19-NI-001
Ophthalmology
Tackling Genetic Eye Diseases with Novel RNA Therapies
PAP-Q4-19-CL-027
Alzheimer's Disease
The Self-Protein Challenge
PAP-Q4-19-CL-002
Alzheimer's Disease
Innovating the Approach to Neurological Disease Treatment
PAP-Q4-19-CL-004
CAR-T
Leveraging Natural Killer Cells as CAR-T Therapies
PAP-Q4-19-CL-013
Immunology
Driving Drug Discovery Using Patients’ Immune Response
PAP-Q4-19-CL-019
Bacteria Engineering
A Triplex Approach to Bacteria Engineering
PAO-M09-19-NI-021
Joint Venture
SEngine Precision Medicine and Atomwise Announce Strategic Joint Venture to Accelerate Novel Drug Discovery
PR-M09-19-NI-031
«
3
8
»